Prescrire International - Free Special Edition - 2022

Howwe work

Prescrire’s rigorous, collective editorial process has beenfine-tuned over the years Prescrire’s reviews, written by specially trained health

professionals, are based on an exhaustive search of the literature, and undergo scrutiny by a large panel of outside reviewers plus rigorous quality-control procedures.

Editors free fromconflicts of interest The absence of any direct or indirect financial links to the pharmaceutical industry is an absolute requirement to be a member of thePrescrire team. Any such linkwouldbe cause for dismissal from the Prescrire Editorial Staff. Avast network of reviewers Once they are in an advanced stage of editing and quality control, all draft reviews are sent to outside reviewers (10 to 40 reviewers read each draft at this stage). These reviewers critique each article in terms of content, style, relevance, newsworthiness, presentationof arguments andusefulness in daily practice. The reviewers are specialists in the subject being discussed, methodologists, or healthcare profession- als representative of Prescrire’s readers (and chosen from their midst).

All the reviews published in La Revue Prescrire (aside from a few clearly labelled exceptions, such as readers’ letters) are written by Prescrire’s Editorial Staff. Prescrire does not publish unsolicitedmanuscripts fromoutside contributors. The production of reviews draws upon a wide range of skills, all exercised under the supervision of Prescrire’s edi tors. This teamapproach is reflected in the collective byline “©Prescrire”. Written and edited by healthcare professionals Most of Prescrire’s editors are physicians (both in individual practice or on hospital staff ), pharma cists (working in pharmacies or hospitals), nurses and dentists. A few are economists or journalists with specific expertise in the area of healthcare. All Prescrire edi tors have received extensive in-house training in Prescrire’s editorial production process.

@PrescrireInternational

@PrescrireInt

Follow Prescrire International A critical eye on new drugs authorised in Europe

Keep up with the latest from Prescrire’s editors, and support our values of independence and quality information.